When most healthcare companies discuss digital transformation, they typically mean electronic medical records or telemedicine platforms.

But for Prenetics Global Limited, a publicly-traded health sciences firm, going digital meant something entirely next level: a $20 million Bitcoin treasury strategy that adds its name to a growing list of companies adopting a Bitcoin acquisition strategy.

The Nasdaq-listed genomics and digital health company disclosed Wednesday that it has acquired 187.42 BTC at an average price of $106,712 using Kraken's custody platform. The purchase represents the beginning of what Prenetics calls a "comprehensive" Bitcoin strategy approved by its board, with plans for substantial future expansion.

In a statement, the firm said the investment forms part of a plan for "the dawn of a new era" in which domains such as genomics, personalized medicine, and digital assets will "will intersect in ways that could revolutionize" how we think about health, wealth, and longevity, Prenetics CEO Danny Yeung said in a statement.$BTC